Roche's Virtual Pipeline Event
Phase 2 results of the bispecific VEGF/Ang2 antibody RG7716 in diabetic macula edema presented at Angiogenesis 2018
On-demand webcast
Agenda
- Ophthalmology overview
Jason Ehrlich, M.D. Ph.D., Senior Group Medical Director, Ophthalmology - BOULEVARD: Phase 2 results of the bispecific VEGF/Ang2 antibody RG7716 in diabetic macula edema
Sascha Fauser, M.D., Head pRED Ophthalmology